Prostaglandin Synthetase System—Resolution into Oxygenase and Isomerase Components
AUTOR(ES)
Miyamoto, Tsumoru
RESUMO
The microsomal fraction of bovine vesicular gland catalyzed the conversion of [1-14C]8,11,14-eicosatrienoic acid to prostaglandin E1 in the presence of tryptophan, hemoglobin, and glutathione. The prostaglandin synthetase system was solubilized by treatment of the microsomal fraction with Tween 20 in the presence of ethylene glycol. DEAE-cellulose column chromatography separated the enzyme into two fractions (Fractions I and II), both of which were required for prostaglandin E1 synthesis. When Fraction I alone was incubated with 8,11,14-eicosatrienoic acid, an unstable compound accumulated. This compound was converted to prostaglandin E1 by the addition of Fraction II. On the basis of its RF values on thin-layer chromatography, its reduction to prostaglandin F1α with stannous chloride, and the decomposition to prostaglandins F1α, E1, and D1 at room temperature, the unstable intermediate was tentatively identified to be the 9,11-endoperoxide derivative, referred to previously as prostaglandin R1 (Nugteren et al. (1973) Biochim. Biophys. Acta 326, 448-461) or prostaglandin H1 (Hamberg et al. (1974) Proc. Nat. Acad. Sci. USA 71, 345-349). Of the three cofactors mentioned above, Fraction I required both tryptophan and hemoglobin, while only glutathione was necessary for Fraction II. Anti-inflammatory agents such as indomethacin and aspirin were inhibitory to Fraction I.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=433832Documentos Relacionados
- Component A of the methyl coenzyme M methylreductase system of Methanobacterium: resolution into four components.
- Component A3 of the methylcoenzyme M methylreductase system of Methanobacterium thermoautotrophicum delta H: resolution into two components.
- Resolution of human transcription factor TFIIIC into two functional components.
- The Kallikrein-Kinin System in Bartter's Syndrome and Its Response to Prostaglandin Synthetase Inhibition
- Prostaglandin Synthetase Inhibitors